公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA取消

39 记录

产品持有公司班级有效性
Toxoplasma gondii (IgA)81148560030EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV03/10/2036
Anti-Treponema pallidum ELISA 2.0 (IgGM)10338930359EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV10/08/2036
Zika virus IgG81148560018EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV18/04/2036
Zika virus IgM81148560019EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV18/04/2036
Trypanosoma cruzi IgG81148560013EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV28/12/2035
Anti-Toxoplasma gondii ELISA 2.0 (IgG)10338930339EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV24/11/2035
Epstein-barr antígeno nuclear IgG10338930133EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV20/10/2035
Chlamydia trachomatis IgM81148560007EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV10/08/2035
Epstein-barr capsídeo viral IgG10338930122EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV09/06/2035
Epstein-barr capsídeo viral IgA10338930121EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV02/06/2035
Anti-Chlamydia trachomatis MIF 1 (IgM)10338930329EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV28/04/2035
Anti-Chlamydia trachomatis MIF 1 (IgG)10338930330EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV28/04/2035
Anti-Chlamydia trachomatis MIF 1 (IgA)10338930331EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV28/04/2035
IF: Toxoplasma gondii IgG10338930177EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV02/03/2035
IF: Toxoplasma gondii IgM10338930179EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV02/03/2035
Treponema pallidum (IgM)10338930149EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV22/12/2034
Treponema pallidum (IgG)10338930150EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV22/12/2034
Epstein-Barr capsídeo viral IgM10338930132EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV02/12/2034
Anti-Citomegalovírus IgM10338930126EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV13/10/2034
Anti-Citomegalovírus em LCR (IgG)10338930128EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV13/10/2034
Anti-Citomegalovírus IgG10338930130EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV13/10/2034
Anti-Citomegalovírus IgG avidez10338930117EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV01/09/2034
Chlamydia pneumoniae (IgG)10338930105EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV25/08/2034
Chlamydia pneumoniae (IgA)10338930108EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV25/08/2034
Chlamydia trachomatis (IgG)10338930110EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV25/08/2034

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家